Bayer to buy part of U.S. pharmaceutical companny Merck for USD 14.2 billion

Source: Beta Wednesday, 07.05.2014. 13:26
Comments
Podeli

(Photo: Ivana Vuksa)
The German drug maker Bayer plans to acquire Merck's consumer care business for $14.2 billion, a deal that will make Bayer one of the largest providers of over-the-counter products, giving this company control of several well-known brand names, including Claritin, Coppertone and Dr. Scholl’s.

Bayer Chief Executive Marijn Dekkers said Tuesday that the proposed agreement represented "a big landmark on the company's path to becoming a global leader in attracting the companies that produce over-the-counter drugs".

Bayer announced that this acquisition would make it a leader in North and South America when it comes to over-the-counter retail products.

This company already owns some main OTC brands such as painkillers Alev and Alka-Selcer and the vitamin One-a-day.

Comments
Your comment
Full information is available only to commercial users-subscribers and it is necessary to log in.

Forgot your password? Click here HERE

For free test use, click HERE

Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno, uz konsultacije sa našim ekspertima.